Do analysts prefer SXTC or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, SXTC or JAGX?

China SXT Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio China SXT Pharmaceuticals $1.14M 1.08 -$6.20M N/A N/A Jaguar Animal Health $11.51M 0.36 -$53.43M -$248.88 N/A

Is SXTC or JAGX more profitable?

China SXT Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Company Net Margins Return on Equity Return on Assets China SXT Pharmaceuticals N/A N/A N/A Jaguar Animal Health -187.88% N/A -131.45%

Do analysts prefer CMND or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ARTL or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artelo Biosciences 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer ARTL or JAGX?

In the previous week, Artelo Biosciences had 4 more articles in the media than Jaguar Animal Health. MarketBeat recorded 6 mentions for Artelo Biosciences and 2 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.90 beat Artelo Biosciences' score of 0.14 indicating that Jaguar Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artelo Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Jaguar Animal Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CDT or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CDT Equity 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer CDT or JAGX?

In the previous week, CDT Equity had 8 more articles in the media than Jaguar Animal Health. MarketBeat recorded 10 mentions for CDT Equity and 2 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.90 beat CDT Equity's score of 0.89 indicating that Jaguar Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CDT Equity 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Jaguar Animal Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend JAGX or BPTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bio-Path 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Jaguar Animal Health (JAGX) Competitors

$0.79 -0.02 (-2.32%)

As of 04:00 PM Eastern

Compare

JAGX vs. SXTC, CMND, ARTL, CDT, and BPTH

Should you buy Jaguar Animal Health stock or one of its competitors? Jaguar Animal Health's main competitors and comparable companies include China SXT Pharmaceuticals (SXTC), Clearmind Medicine (CMND), Artelo Biosciences (ARTL), CDT Equity (CDT), and Bio-Path (BPTH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Jaguar Animal Health compare to China SXT Pharmaceuticals?

China SXT Pharmaceuticals (NASDAQ:SXTC) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

China SXT Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
China SXT Pharmaceuticals	$1.14M	1.08	-$6.20M	N/A	N/A
Jaguar Animal Health	$11.51M	0.36	-$53.43M	-$248.88	N/A

5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by company insiders. Comparatively, 0.2% of Jaguar Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

China SXT Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%.

Company	Net Margins	Return on Equity	Return on Assets
China SXT Pharmaceuticals	N/A	N/A	N/A
Jaguar Animal Health	-187.88%	N/A	-131.45%

In the previous week, China SXT Pharmaceuticals and China SXT Pharmaceuticals both had 2 articles in the media. China SXT Pharmaceuticals' average media sentiment score of 1.44 beat Jaguar Animal Health's score of 0.90 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
China SXT Pharmaceuticals	Positive
Jaguar Animal Health	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
China SXT Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

China SXT Pharmaceuticals has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market.

Summary

China SXT Pharmaceuticals beats Jaguar Animal Health on 7 of the 9 factors compared between the two stocks.

How does Jaguar Animal Health compare to Clearmind Medicine?

Clearmind Medicine (NASDAQ:CMND) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

In the previous week, Jaguar Animal Health had 1 more articles in the media than Clearmind Medicine. MarketBeat recorded 2 mentions for Jaguar Animal Health and 1 mentions for Clearmind Medicine. Clearmind Medicine's average media sentiment score of 0.99 beat Jaguar Animal Health's score of 0.90 indicating that Clearmind Medicine is being referred to more favorably in the media.

Company	Overall Sentiment
Clearmind Medicine	Positive
Jaguar Animal Health	Positive

Clearmind Medicine has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-143.79%	-88.51%
Jaguar Animal Health	-187.88%	N/A	-131.45%

96.1% of Clearmind Medicine shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 0.2% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Clearmind Medicine has higher earnings, but lower revenue than Jaguar Animal Health. Clearmind Medicine is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A
Jaguar Animal Health	$11.51M	0.36	-$53.43M	-$248.88	N/A

Clearmind Medicine has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Clearmind Medicine beats Jaguar Animal Health on 7 of the 13 factors compared between the two stocks.

How does Jaguar Animal Health compare to Artelo Biosciences?

Artelo Biosciences (NASDAQ:ARTL) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artelo Biosciences	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

0.9% of Artelo Biosciences shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 3.2% of Artelo Biosciences shares are held by company insiders. Comparatively, 0.2% of Jaguar Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Artelo Biosciences has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market.

Artelo Biosciences has higher earnings, but lower revenue than Jaguar Animal Health. Artelo Biosciences is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artelo Biosciences	N/A	N/A	-$12.88M	-$16.80	N/A
Jaguar Animal Health	$11.51M	0.36	-$53.43M	-$248.88	N/A

In the previous week, Artelo Biosciences had 4 more articles in the media than Jaguar Animal Health. MarketBeat recorded 6 mentions for Artelo Biosciences and 2 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.90 beat Artelo Biosciences' score of 0.14 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artelo Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Artelo Biosciences has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Artelo Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artelo Biosciences	N/A	-518.27%	-194.29%
Jaguar Animal Health	-187.88%	N/A	-131.45%

Summary

Jaguar Animal Health beats Artelo Biosciences on 7 of the 13 factors compared between the two stocks.

How does Jaguar Animal Health compare to CDT Equity?

CDT Equity (NASDAQ:CDT) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

3.3% of CDT Equity shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 7.3% of CDT Equity shares are held by insiders. Comparatively, 0.2% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CDT Equity has higher earnings, but lower revenue than Jaguar Animal Health. Jaguar Animal Health is trading at a lower price-to-earnings ratio than CDT Equity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CDT Equity	N/A	N/A	-$39.22M	-$3.35 thousand	N/A
Jaguar Animal Health	$11.51M	0.36	-$53.43M	-$248.88	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CDT Equity	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, CDT Equity had 8 more articles in the media than Jaguar Animal Health. MarketBeat recorded 10 mentions for CDT Equity and 2 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.90 beat CDT Equity's score of 0.89 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CDT Equity	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CDT Equity has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat CDT Equity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CDT Equity	N/A	-72.25%	-55.44%
Jaguar Animal Health	-187.88%	N/A	-131.45%

CDT Equity has a beta of 1.52, suggesting that its share price is 52% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market.

Summary

CDT Equity beats Jaguar Animal Health on 7 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Bio-Path?

Jaguar Animal Health (NASDAQ:JAGX) and Bio-Path (NASDAQ:BPTH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bio-Path	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 5.7% of Bio-Path shares are owned by institutional investors. 0.2% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 0.7% of Bio-Path shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Jaguar Animal Health has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market. Comparatively, Bio-Path has a beta of -0.51, meaning that its stock price is 151% less volatile than the broader market.

In the previous week, Jaguar Animal Health had 2 more articles in the media than Bio-Path. MarketBeat recorded 2 mentions for Jaguar Animal Health and 0 mentions for Bio-Path. Jaguar Animal Health's average media sentiment score of 0.90 beat Bio-Path's score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
Bio-Path	Neutral

Bio-Path has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Bio-Path's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-187.88%	N/A	-131.45%
Bio-Path	N/A	-2,842.40%	-337.48%

Bio-Path has lower revenue, but higher earnings than Jaguar Animal Health. Bio-Path is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.36	-$53.43M	-$248.88	N/A
Bio-Path	N/A	N/A	-$16.08M	-$1.09	N/A

Summary

Jaguar Animal Health beats Bio-Path on 9 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.09M	$12.01B	$7.12B	$12.85B
Dividend Yield	N/A	2.62%	2.54%	11.27%
P/E Ratio	0.00	785.16	272.89	25.51
Price / Sales	0.36	957.31	686.41	123.12
Price / Cash	N/A	15.32	28.74	36.03
Price / Book	-0.01	10.48	11.06	6.34
Net Income	-$53.43M	$2.83B	$3.47B	$349.45M
7 Day Performance	-13.26%	0.23%	1.28%	-0.10%
1 Month Performance	-20.89%	5.33%	8.29%	4.36%
1 Year Performance	-98.61%	6.01%	24.29%	14.91%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.2103 of 5 stars	$0.79 -2.3%	N/A	-98.6%	$4.09M	$11.51M	N/A	50	Positive News
SXTC China SXT Pharmaceuticals	0.7787 of 5 stars	$5.13 +36.8%	N/A	-100.0%	$2.07M	$1.14M	N/A	90	Positive News High Trading Volume
CMND Clearmind Medicine	1.5084 of 5 stars	$1.96 +3.7%	N/A	-99.6%	$1.93M	N/A	N/A	N/A	High Trading Volume
ARTL Artelo Biosciences	0.749 of 5 stars	$0.73 +1.2%	$54.00 +7,298.3%	-97.6%	$1.84M	N/A	N/A	5	News Coverage Short Interest Decrease Gap Down High Trading Volume
CDT CDT Equity	0.6748 of 5 stars	$2.89 +3.2%	N/A	-99.9%	$1.77M	N/A	N/A	3	Analyst Upgrade Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. SXTC, CMND, ARTL, CDT, and BPTH

How does Jaguar Animal Health compare to China SXT Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Clearmind Medicine?

Summary

How does Jaguar Animal Health compare to Artelo Biosciences?

Summary

How does Jaguar Animal Health compare to CDT Equity?

Summary

How does Jaguar Animal Health compare to Bio-Path?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. SXTC, CMND, ARTL, CDT, and BPTH

How does Jaguar Animal Health compare to China SXT Pharmaceuticals?

Which has stronger earnings & valuation, SXTC or JAGX?

Do institutionals & insiders have more ownership in SXTC or JAGX?

Is SXTC or JAGX more profitable?

Does the media favor SXTC or JAGX?

Do analysts prefer SXTC or JAGX?

Which has more volatility & risk, SXTC or JAGX?

Summary

How does Jaguar Animal Health compare to Clearmind Medicine?

Does the media favor CMND or JAGX?

Is CMND or JAGX more profitable?

Do institutionals and insiders have more ownership in CMND or JAGX?

Which has better valuation & earnings, CMND or JAGX?

Which has more volatility and risk, CMND or JAGX?

Do analysts prefer CMND or JAGX?

Summary

How does Jaguar Animal Health compare to Artelo Biosciences?

Do analysts rate ARTL or JAGX?

Do institutionals & insiders believe in ARTL or JAGX?

Which has more risk & volatility, ARTL or JAGX?

Which has stronger earnings and valuation, ARTL or JAGX?

Does the media prefer ARTL or JAGX?

Is ARTL or JAGX more profitable?

Summary

How does Jaguar Animal Health compare to CDT Equity?

Do insiders & institutionals believe in CDT or JAGX?

Which has better valuation and earnings, CDT or JAGX?

Do analysts rate CDT or JAGX?

Does the media prefer CDT or JAGX?

Is CDT or JAGX more profitable?

Which has more risk and volatility, CDT or JAGX?

Summary

How does Jaguar Animal Health compare to Bio-Path?

Do analysts recommend JAGX or BPTH?

Do insiders and institutionals believe in JAGX or BPTH?

Which has more volatility & risk, JAGX or BPTH?

Does the media refer more to JAGX or BPTH?

Is JAGX or BPTH more profitable?

Which has higher earnings and valuation, JAGX or BPTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools